Tribunal Federal de EE.UU. falla a favor de Allergan, Inc. y emite prohibicin permanente contra Merz Pharmaceuticals y Merz Aes

Health and Fitness Health and Fitness

Mon, March 19, 2012

[ Mon, Mar 19th 2012 ] - Market Wire

Marshall Edwards Announces Terms for Rights Offering to Stockholders

[ Mon, Mar 19th 2012 ] - Market Wire

MMRGlobal Plans on Announcing Increased Revenues on March 30

[ Mon, Mar 19th 2012 ] - Market Wire

Rosetta Genomics to Present Multiple Poster Prese .. Meeting of the United States and Canadian Academy

[ Mon, Mar 19th 2012 ] - Market Wire

Stellar to Hold Conference Call re Health Canada .. of CAMBIA(R) for the Treatment of Acute Migraines

[ Mon, Mar 19th 2012 ] - Market Wire

Life Technologies Launches GeneArt Precision TALs

[ Mon, Mar 19th 2012 ] - Market Wire

Varian Medical Systems Schedules Second Quarter FY2012 News Release and Conference Call

[ Mon, Mar 19th 2012 ] - Market Wire

Alnylam Initiates Phase I Clinical Study of ALN-T .. geting Transthyretin (TTR) for the Treatment of T

[ Mon, Mar 19th 2012 ] - Market Wire

ZELTIQ Aesthetics, Inc. Names Mike Genau President of Its North American Franchise

[ Mon, Mar 19th 2012 ] - Market Wire

Solta Medical to Present at Upcoming Investor Conferences

[ Mon, Mar 19th 2012 ] - Market Wire

Covidien annonce la signature daun accord dfinitif en vue de laacquisition de superDimension, Ltd.

[ Mon, Mar 19th 2012 ] - Market Wire

Covidien anuncia acordo final para adquirir a superDimension, Ltd.

[ Mon, Mar 19th 2012 ] - Market Wire

New Study Finds Cambridge Heartas MTWA Test to Be a Powerful Predictor of Sudden Cardiac Arrest

[ Mon, Mar 19th 2012 ] - Market Wire

Implant Sciences Appoints Dr. Bill McGann as Chief Operating Officer

[ Mon, Mar 19th 2012 ] - Market Wire

Covidien Announces Definitive Agreement to Acquire superDimension, Ltd.

[ Mon, Mar 19th 2012 ] - Market Wire

Covidien annuncia accordo definitivo per acquisire superDimension, Ltd.

[ Mon, Mar 19th 2012 ] - Market Wire

Delcath Announces Agreement with Instituto Oncologico Baselga for Launch of CHEMOSAT in Spain

[ Mon, Mar 19th 2012 ] - Market Wire

Illumina Files Definitive Proxy Materials and Sends Letter to Stockholders

[ Mon, Mar 19th 2012 ] - Market Wire

Co-Principal Investigator for OncoSec's Phase II .. o Speak at 70th Annual American Academy of Dermat

[ Mon, Mar 19th 2012 ] - Market Wire

Cytori Breast Reconstruction Cell Therapy Trial Results Published

Sun, March 18, 2012

[ Sun, Mar 18th 2012 ] - Market Wire

STATS ChipPAC Provides Updated Outlook for First Quarter 2012

Fri, March 16, 2012

[ Fri, Mar 16th 2012 ] - Market Wire

Kensey Nash Announces Mediated Settlement With St .. License Disputes and 5 Year Extension and Expansi

[ Fri, Mar 16th 2012 ] - Market Wire

Cubist Opens Expanded Research and Development Facility

[ Fri, Mar 16th 2012 ] - Market Wire

The Law Firm of Levi &;; Korsinsky Noti .. Their Investment in Columbia Laboratories Inc. o

[ Fri, Mar 16th 2012 ] - Market Wire

HeartWare Receives 54-Patient Allotment From FDA .. ol for Pivotal U.S. Bridge-to-Transplant Clinical

[ Fri, Mar 16th 2012 ] - Market Wire

Health Canada Approves CAMBIA(R) for the Treatment of Acute Migraine

[ Fri, Mar 16th 2012 ] - Market Wire

OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering

[ Fri, Mar 16th 2012 ] - Market Wire

HCA Named to Ethisphereas 2012 aWorldas Most Ethical Companiesa

[ Fri, Mar 16th 2012 ] - Market Wire

Cynosure to Present at 2012 Maxim Group Growth Conference

[ Fri, Mar 16th 2012 ] - Market Wire

Analytical Reports on Teva Pharmaceutical Industr .. tories Inc. - Drug Manufacturers Flexing Pipeline

[ Fri, Mar 16th 2012 ] - Market Wire

Equity Research on Unitedhealth Group Inc. and CIGNA Corp. - Health Care and the Economic Recovery

[ Fri, Mar 16th 2012 ] - Market Wire

ImmunoCellular Appoints Dr. Richard Chin To Board of Directors

[ Fri, Mar 16th 2012 ] - Market Wire

FDA Grants Cytori 510(k) Clearance for Puregraft(R) 850

[ Fri, Mar 16th 2012 ] - Market Wire

Echo Therapeutics, Inc. Announces 2011 Financial Results

[ Fri, Mar 16th 2012 ] - Market Wire

Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery

[ Fri, Mar 16th 2012 ] - Market Wire

American Oriental Bioengineering Inc. Announces D .. Filing of its Annual Report on Form 10-K for 2011

[ Fri, Mar 16th 2012 ] - Market Wire

Threshold Pharmaceuticals' TH-302 Receives Orphan .. pean Union for the Treatment of Soft Tissue Sarco

[ Fri, Mar 16th 2012 ] - Market Wire

Cambridge Heart Announces Microvolt T-Wave Alternans Receives Reimbursement Coverage in Japan

[ Fri, Mar 16th 2012 ] - Market Wire

Repligen Reports Financial Results for the Quarte .. nd Nine-Month Fiscal Year Ended December 31, 2011

[ Fri, Mar 16th 2012 ] - Market Wire

First Patient Enrolled Into European Registry for .. Stimulation in Patients With Refractory Epilepsy

Thu, March 15, 2012

[ Thu, Mar 15th 2012 ] - Market Wire

Genomma Lab Internacional to Nominate Slate of Fi .. Election at Prestige Brandsa 2012 Annual Meeting

[ Thu, Mar 15th 2012 ] - Market Wire

Anthera Provides Corporate Update on Recent Activities

[ Thu, Mar 15th 2012 ] - Market Wire

AdCare Health Systems Acquires Two Skilled Nursing Facilities in Oklahoma

[ Thu, Mar 15th 2012 ] - Market Wire

Leisureworld Announces March Dividend

[ Thu, Mar 15th 2012 ] - Market Wire

Verisante Technology, Inc. Announces Exclusive Di .. Agreement With Clarion Medical Technologies Inc.

[ Thu, Mar 15th 2012 ] - Market Wire

MethylGene Reports Fourth Quarter and Full Year 2011 Financial Results

[ Thu, Mar 15th 2012 ] - Market Wire

Amgen Announces 2012 Second Quarter Dividend

[ Thu, Mar 15th 2012 ] - Market Wire

Cytomedix Announces Publication in American Heart .. e Phase I Clinical Data Using ALD-201 to Treat Is

[ Thu, Mar 15th 2012 ] - Market Wire

Cynosure Introduces Enhanced Elite+ and Apogee+ Workstations for Faster Aesthetic Treatments

[ Thu, Mar 15th 2012 ] - Market Wire

Celsion Reports Year End 2011 Financial Results and Provides Business Update

[ Thu, Mar 15th 2012 ] - Market Wire

GenVec Reports Fourth Quarter and 2011 Year-End Financial Results

[ Thu, Mar 15th 2012 ] - Market Wire

Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment

[ Thu, Mar 15th 2012 ] - Market Wire

United Therapeutics Files Lawsuit Against Sandoz for Infringement of Remodulin Patents

[ Thu, Mar 15th 2012 ] - Market Wire

Amedisys Scores 19% Above National Average on Treatment Goals Met at Home

[ Thu, Mar 15th 2012 ] - Market Wire

DaVita Clinics Give $67,000 to Ohio Charities

[ Thu, Mar 15th 2012 ] - Market Wire

Delcath Announces Agreement With Institut Gustave .. nch of Hepatic CHEMOSAT Delivery System in France

[ Thu, Mar 15th 2012 ] - Market Wire

InVivo Therapeutics Reports 2011 Financial Results, Provides Business Update

[ Thu, Mar 15th 2012 ] - Market Wire

Abbott Announces Patient Enrollment in Two Phase .. ab) for Moderate to Severe Hidradenitis Suppurati

[ Thu, Mar 15th 2012 ] - Market Wire

PAREXEL Global Survey Results Identify Top Concer .. iopharma Industry in Achieving Commercial Success

Wed, March 14, 2012

[ Wed, Mar 14th 2012 ] - Market Wire

Flamel Technologies Announces Acquisition of clat Pharmaceuticals

[ Wed, Mar 14th 2012 ] - Market Wire

Teva Announces Launch of Generic Lexapro in the U .. ; Awarded 180-Day Period of Marketing Exclusivity

[ Wed, Mar 14th 2012 ] - Market Wire

Guided Therapeutics to Report Q4 2011 Results and Hold Conference Call

[ Wed, Mar 14th 2012 ] - Market Wire

Securities Lawyers Seeking More Money, Informatio .. es Stockholders in Buyout, Announces Goldfarb LLP

[ Wed, Mar 14th 2012 ] - Market Wire

Goldfarb LLP Securities Lawyers Seek More Money, .. formation for Shareholders in Zoll Medical Buyout

[ Wed, Mar 14th 2012 ] - Market Wire

Biogen Idec Takes Option to MAKScientific MS Program

[ Wed, Mar 14th 2012 ] - Market Wire

Generex Subsidiary Antigen Express Announces Publ .. its Proprietary Therapeutic Vaccine Technology in

[ Wed, Mar 14th 2012 ] - Market Wire

Threshold Pharmaceuticals Doses First Patient in .. nical Trial Evaluating TH-302 in Multiple Myeloma

[ Wed, Mar 14th 2012 ] - Market Wire

Trimel Pharmaceuticals Corporation Provides Update on Operational Leadership

[ Wed, Mar 14th 2012 ] - Market Wire

Verastem, Inc. Reports Year-End 2011 Financial Results

[ Wed, Mar 14th 2012 ] - Market Wire

Covidien meldt resultaten van 2012 jaarlijkse algemene vergadering

[ Wed, Mar 14th 2012 ] - Market Wire

DaVita Thanks its 1,500 Dietitianson Registered Dietitian Day

[ Wed, Mar 14th 2012 ] - Market Wire

Federal Court Grants Request by BioDelivery Sciences for Stay of MonoSol Litigation

[ Wed, Mar 14th 2012 ] - Market Wire

Alnylam Retains Key Claims for Kinesin Spindle Pr .. ein (KSP) RNAi Patent in Interference Proceedings

[ Wed, Mar 14th 2012 ] - Market Wire

Synthetic Biologics Announces Completion of Enrol .. l Trial of Oral Trimestaa" for Multiple Sclerosis

[ Wed, Mar 14th 2012 ] - Market Wire

Marina Biotech and ProNAi Therapeutics Announce L .. nt for the Development of DNAi-Based Therapeutics

[ Wed, Mar 14th 2012 ] - Market Wire

OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial

[ Wed, Mar 14th 2012 ] - Market Wire

Sunshine Heart Announces FDA Completes Review of C-Pulse(R) Feasibility Data

[ Wed, Mar 14th 2012 ] - Market Wire

Perceptive Informatics Global Survey Results Show .. ption of Web-based RTSM Systems by Clinical Sites

Tue, March 13, 2012

[ Tue, Mar 13th 2012 ] - Market Wire

Kensey Nash Corporation Declares a Quarterly Dividend of $0.25 Per Share

[ Tue, Mar 13th 2012 ] - Market Wire

ActiveCare Acquires 4G Biometrics in Move to Addr .. ing Needs of Diabetic Patients and Their Families

[ Tue, Mar 13th 2012 ] - Market Wire

SciClone Reports Financial Results for the Fourth Quarter and Year 2011 and Outlook for 2012

[ Tue, Mar 13th 2012 ] - Market Wire

VELscope Vx(R) Approved for Use by AppleWhite Dental Partners

[ Tue, Mar 13th 2012 ] - Market Wire

Alkermes plc Completes Secondary Offering of 24,150,000 Ordinary Shares Held by Elan

[ Tue, Mar 13th 2012 ] - Market Wire

Endo Files Amended Citizen Petition Seeking Publi .. Safety and Efficacy Issues Prior to Approval of a

[ Tue, Mar 13th 2012 ] - Market Wire

NuPathe to Report Fourth Quarter and Full Year 20 .. d Hold Conference Call on Tuesday, March 20, 2012

[ Tue, Mar 13th 2012 ] - Market Wire

Comprehensive Care Corporation Celebrates 43rd Anniversary

[ Tue, Mar 13th 2012 ] - Market Wire

Enzo Biochemas Clinical Laboratory Applies for NY .. oval for First Assay Based on Its AmpiProbea" Amp

[ Tue, Mar 13th 2012 ] - Market Wire

Codexis to Present at Sidotias Emerging Growth Institutional Investor Forum

[ Tue, Mar 13th 2012 ] - Market Wire

OncoSec President and CEO Contributes to Today's Medical Developments

[ Tue, Mar 13th 2012 ] - Market Wire

Aeolus to Present at Roth Capital Partners' 24th Annual Growth Stock Conference

[ Tue, Mar 13th 2012 ] - Market Wire

Boston Scientific vor der bernahme von Cameron Health, Inc.

[ Tue, Mar 13th 2012 ] - Market Wire

Boston Scientific comprar Cameron Health, Inc.

[ Tue, Mar 13th 2012 ] - Market Wire

Acquisition de Cameron Health, Inc. par Boston Scientific

[ Tue, Mar 13th 2012 ] - Market Wire

Boston Scientific annuncia l'acquisizione di Cameron Health, Inc.

[ Tue, Mar 13th 2012 ] - Market Wire

Inovio Pharmaceuticals' PENNVAX-B HIV Vaccine Dem .. ell Immune Responses in Therapeutic Vaccine Trial

[ Tue, Mar 13th 2012 ] - Market Wire

AstraZeneca Files Lawsuit against the FDA for Dec .. rding Quetiapine Product Labeling and Exclusivity

Mon, March 12, 2012

[ Mon, Mar 12th 2012 ] - Market Wire

Cannabis Science Confirms Target Indication for F .. eeting with the FDA with Its Team of FDA Speciali

[ Mon, Mar 12th 2012 ] - Market Wire

Syneron to Acquire Assets of TransPharma Medical Ltd.

[ Mon, Mar 12th 2012 ] - Market Wire

Pfizer and Bristol-Myers Squibb Look to Reshape Anticoagulant Market

[ Mon, Mar 12th 2012 ] - Market Wire

Equity Research on Mylan Inc. and Watson Pharmace .. Makers Continue to Capitalize on Expiring Patents

[ Mon, Mar 12th 2012 ] - Market Wire

American Medical Association Adopts New Category III CPT Codes for Vagus Nerve Blocking Therapy

[ Mon, Mar 12th 2012 ] - Market Wire

Enzon Reports Fourth-Quarter and Full-Year 2011 Results

[ Mon, Mar 12th 2012 ] - Market Wire

WaferGen Appoints Ivan Trifunovich President, CEO, and Director

[ Mon, Mar 12th 2012 ] - Market Wire

Infinity Appoints Two Experienced Industry Leaders to Its Board of Directors

[ Mon, Mar 12th 2012 ] - Market Wire

Zynex Acquires NeuroDyne Medical, Corp.

[ Mon, Mar 12th 2012 ] - Market Wire

International Stem Cell Corporation Completes $5 .. and Elects Jim Berglund to the Board of Directors

[ Mon, Mar 12th 2012 ] - Market Wire

ImmunoCellular Therapeutics Reports Manufacturing Process Data for ICT-107

[ Mon, Mar 12th 2012 ] - Market Wire

Threshold Pharmaceuticals' TH-302 to Be Featured .. Cancer Hosted by the New York Academy of Sciences

[ Mon, Mar 12th 2012 ] - Market Wire

ONSOLIS Relaunch Postponed Pending Product Modification

[ Mon, Mar 12th 2012 ] - Market Wire

Given Imaging Announces Publication of Colon Capsule Endoscopy Guidelines in Endoscopy

[ Mon, Mar 12th 2012 ] - Market Wire

Teleflex Appoints Thomas E. Powell Senior Vice President & Chief Financial Officer

[ Mon, Mar 12th 2012 ] - Market Wire

PAREXEL Experts to Address Approaches to Accelera .. ase Development Decisions at ASCPT Annual Meeting

[ Mon, Mar 12th 2012 ] - Market Wire

Medisafe 1 Technologies Signs Marketing and Distribution Agreement with Health Product Carrier

[ Mon, Mar 12th 2012 ] - Market Wire

Sunshine Heart Provides FAQ Regarding Transmutation of CDIs to Common Stock

Sat, March 10, 2012

[ Sat, Mar 10th 2012 ] - Market Wire

Gegevens tonen aan dat Gilead';;s .. ferieur is aan op protease gebaseerd regime na 48

[ Sat, Mar 10th 2012 ] - Market Wire

I dati di un secondo importante studio di Fase II .. t del regime Quad di Gilead per il trattamento de

[ Sat, Mar 10th 2012 ] - Market Wire

Quad-HIV-Prparat von Gilead nach 48 Wochen nicht .. g auf Protease-Basis: Beleg durch Daten einer zwe

[ Sat, Mar 10th 2012 ] - Market Wire

Los datos muestran que el rgimen Quad de Gilead p .. rgimen basado en proteasa a las 48 semanas en un

[ Sat, Mar 10th 2012 ] - Market Wire

Gegevens tonen aan dat Gilead's Quad-regime voor .. protease gebaseerd regime na 48 weken, in tweede

[ Sat, Mar 10th 2012 ] - Market Wire

Tenet to Speak at the Barclays Capital Healthcare Conference on March 14th

[ Sat, Mar 10th 2012 ] - Market Wire

Glancy Binkow & Goldberg LLP Announces Lead Plain .. e In The Class Action Lawsuit Against TranS1 Inc.

Fri, March 9, 2012

[ Fri, Mar 09th 2012 ] - Market Wire

Edwards Lifesciences to Present at the 24th Annual ROTH Conference

[ Fri, Mar 09th 2012 ] - Market Wire

Patient Home Monitoring (PHM) Announces February .. s and Growth Figures, Change in Operation Executi

[ Fri, Mar 09th 2012 ] - Market Wire

The Law Firm of Levi amp;; Korsinsky, LLP .. anscend Services, Inc. in Connection with the Sal

[ Fri, Mar 09th 2012 ] - Market Wire

Titan Medical Inc. Files Prospectus Supplement for Unit Offering

[ Fri, Mar 09th 2012 ] - Market Wire

Regeneron Announces Change in Date for Presentati .. arclays Capital 2012 Global Healthcare Conference

[ Fri, Mar 09th 2012 ] - Market Wire

Sequenom, Genworth Financial, Huntsman, New Gold, Huntington Bancshares, and Amarin

[ Fri, Mar 09th 2012 ] - Market Wire

Cantel Medical Corp. to Present at the Sidoti amp .. nth Annual Emerging Growth Institutional Investor

[ Fri, Mar 09th 2012 ] - Market Wire

(NYSE Amex: DXR) Daxor Announces Filing of Two Ad .. onal Patents for Updated Automated Blood Analyzer

[ Fri, Mar 09th 2012 ] - Market Wire

Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on PhotoMedex, Inc.

[ Fri, Mar 09th 2012 ] - Market Wire

Ardea Biosciences Reports Recent Accomplishments .. urth Quarter and Full-Year 2011 Financial Results

[ Fri, Mar 09th 2012 ] - Market Wire

BD to Present at the Barclays Capital Global Healthcare Conference

[ Fri, Mar 09th 2012 ] - Market Wire

Equity Research on Valeant Pharmaceuticals Intern .. n Corp. plc - Drug Delivery Companies Up and Down

[ Fri, Mar 09th 2012 ] - Market Wire

Peregrine Reports Data From Phase II Front-Line Lung Cancer Trial

[ Fri, Mar 09th 2012 ] - Market Wire

Haemonetics Sets Date for Investor/Analyst Meeting

[ Fri, Mar 09th 2012 ] - Market Wire

BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2011 Financial Results

[ Fri, Mar 09th 2012 ] - Market Wire

EntreMed Reports Fourth Quarter and Year-End 2011 Financial Results

[ Fri, Mar 09th 2012 ] - Market Wire

Halozyme Reports Fourth Quarter and Year End 2011 Financial Results and Provides Guidance for 2012

[ Fri, Mar 09th 2012 ] - Market Wire

Delcath Selects Quintiles to Support EU Launch of CHEMOSAT

Thu, March 8, 2012

[ Thu, Mar 08th 2012 ] - Market Wire

BIOLASE Chief Executive Officer to Continue at Rate of $1.00 Annual Salary

[ Thu, Mar 08th 2012 ] - Market Wire

PDL BioPharma Provides First Quarter 2012 Royalty Revenue Guidance of $77 Million

[ Thu, Mar 08th 2012 ] - Market Wire

OncoGenex Pharmaceuticals, Inc. Reports Financial .. and Year End 2011 and Provides Update on Clinical

[ Thu, Mar 08th 2012 ] - Market Wire

Sangamo Presents New Clinical Data at CROI 2012 D .. ive Effects of ZFN Therapeutic for "Functional Cu

[ Thu, Mar 08th 2012 ] - Market Wire

Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System Receives FDA Clearance

[ Thu, Mar 08th 2012 ] - Market Wire

LED Dental Launches Second Step Laboratory Services in Canada

[ Thu, Mar 08th 2012 ] - Market Wire

Amylin Pharmaceuticals Announces Pricing of Public Offering of Common Stock

[ Thu, Mar 08th 2012 ] - Market Wire

USANA Health Sciences Unveils New Charitable Foundation

[ Thu, Mar 08th 2012 ] - Market Wire

MIT Agrees to $3.2 Million in Financing, Includin .. in Convertible Debentures and $1.2 Million in Deb

[ Thu, Mar 08th 2012 ] - Market Wire

Celsion Corporation to Hold Year-End 2011 Financi .. sults Conference Call on Thursday, March 15, 2012

[ Thu, Mar 08th 2012 ] - Market Wire

Michael E. DeBakey VA Medical Center Initiates Ph .. ia with Aeterna Zentaris' Ghrelin Agonist, AEZS-1

[ Thu, Mar 08th 2012 ] - Market Wire

Isis Pharmaceuticals to Present at the Barclays Capital 2012 Global Healthcare Conference

[ Thu, Mar 08th 2012 ] - Market Wire

Implant Sciences Sells More QS-H150 Explosives Trace Detection Devices to Chinese Airports

[ Thu, Mar 08th 2012 ] - Market Wire

OncoSec to Evaluate Potential Predictive or Progn .. t of Solid Tumor Cancers Using OMS ElectroImmunot

[ Thu, Mar 08th 2012 ] - Market Wire

Biodel Inc. to Present at ROTH 24th Annual OC Growth Stock Conference on March 14th, 2012

[ Thu, Mar 08th 2012 ] - Market Wire

Threshold Pharmaceuticals Reports Fourth Quarter .. d Year End 2011 Financial and Operational Results

[ Thu, Mar 08th 2012 ] - Market Wire

Sana Kliniken AG firma un acuerdo con Masimo para .. oluciones de supervisin de pacientes no invasivas

[ Thu, Mar 08th 2012 ] - Market Wire

Regeneron and Bayer Announce Approval of EYLEA (a .. Treatment of Wet Age-Related Macular Degeneratio

Wed, March 7, 2012

[ Wed, Mar 07th 2012 ] - Market Wire

Law Firm Brower Piven Announces Investigation in .. on of Transcend Services, Inc. by Nuance Communic

[ Wed, Mar 07th 2012 ] - Market Wire

Resmed Inc. to Present at Upcoming Conferences

[ Wed, Mar 07th 2012 ] - Market Wire

International Drug &;; Explosives Detec .. ounces Strategic Alliance With an American Compan

[ Wed, Mar 07th 2012 ] - Market Wire

SPX-106T Arrests Development of Atherosclerotic Plaques in Mouse Model of Cardiovascular Disease

[ Wed, Mar 07th 2012 ] - Market Wire

Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial

[ Wed, Mar 07th 2012 ] - Market Wire

Prana Doses First Patient in the "IMAGINE" Phase II Alzheimer's Disease Trial

[ Wed, Mar 07th 2012 ] - Market Wire

EnteroMedics to Present at the 24th Annual ROTH Capital Growth Conference

[ Wed, Mar 07th 2012 ] - Market Wire

Discovery Labs to Hold Conference Call to Discuss FDA Approval of SURFAXIN (lucinactant)

[ Wed, Mar 07th 2012 ] - Market Wire

iBio to Present at the 24th Annual ROTH Conference on March 14

[ Wed, Mar 07th 2012 ] - Market Wire

Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference

[ Wed, Mar 07th 2012 ] - Market Wire

Synthetic Biologics to Present at ROTH Annual Growth Stock Conference

[ Wed, Mar 07th 2012 ] - Market Wire

Transcept Pharmaceuticals to Report Fourth Quarte .. l Results and Host Conference Call on March 14, 2

[ Wed, Mar 07th 2012 ] - Market Wire

Horizon Pharma Enters Into Exclusive Agreement Wi .. ization of LODOTRA(R) (Modified-Release Prednison

[ Wed, Mar 07th 2012 ] - Market Wire

CMS Assigns Payment to Novadaq's SPY Imaging Under OPPS

[ Wed, Mar 07th 2012 ] - Market Wire

Solta Medical Provides Update on Liposonix Launch

[ Wed, Mar 07th 2012 ] - Market Wire

The Ensign Group Acquires an Idaho Skilled Nursing Facility

[ Wed, Mar 07th 2012 ] - Market Wire

OncoSec's OMS ElectroImmunotherapy Technology Pla .. I Merkel Cell Carcinoma Clinical Trial Featured i

[ Wed, Mar 07th 2012 ] - Market Wire

Inovio Appoints Vaccine Industry Leader to its Scientific Advisory Board

Tue, March 6, 2012

[ Tue, Mar 06th 2012 ] - Market Wire

TPI Updated Corporate Presentation at 32nd Cowen's Healthcare Conference

[ Tue, Mar 06th 2012 ] - Market Wire

PharmAthene to Host Year-End 2011 Earnings Conference Call and Webcast on Thursday, March 8, 2012

[ Tue, Mar 06th 2012 ] - Market Wire

ProMetic Secures a $2.5 Million Follow on Agreement

[ Tue, Mar 06th 2012 ] - Market Wire

Lpath Raises $9.3 Million in Equity Financing

[ Tue, Mar 06th 2012 ] - Market Wire

CareFusion To Acquire Pharmacy Automation Technology Leader

[ Tue, Mar 06th 2012 ] - Market Wire

STATS ChipPAC's Scalable 3D eWLB Solutions Delive .. t Advantages Over Substrate-Based Package-on-Pack

[ Tue, Mar 06th 2012 ] - Market Wire

Comprehensive Care Corporation Expands Contract with Nation's Largest Public Health Plan

[ Tue, Mar 06th 2012 ] - Market Wire

More Regulation Looms for the Medical Equipment and Supplies Industry

[ Tue, Mar 06th 2012 ] - Market Wire

Shares of Antares Pharma and Boston Scientific on .. l Equipment and Supplies Industry Soaring in 2012

[ Tue, Mar 06th 2012 ] - Market Wire

Verotoxin and E. coli 0157

[ Tue, Mar 06th 2012 ] - Market Wire

Titan Medical Inc. Announces Memorandum of Unders .. with Switzerland Based Clinique Generale-Beaulieu

[ Tue, Mar 06th 2012 ] - Market Wire

InspireMD Announces its 2011 Year End Financial Results

[ Tue, Mar 06th 2012 ] - Market Wire

Cytokinetics Announces That the European Medicine .. 57 Orphan Medicinal Product Designation for the T

[ Tue, Mar 06th 2012 ] - Market Wire

Rigel Announces Fourth Quarter and Year End 2011 Financial Results

[ Tue, Mar 06th 2012 ] - Market Wire

Shire to Initiate Two Phase 4 Clinical Trials to .. mine dimesylate) Capsules, (CII) to Concerta (met

[ Tue, Mar 06th 2012 ] - Market Wire

Implant Sciences Joins SOSSEC - Consortium of Lea .. rs in Security &;; Defense Technologies

[ Tue, Mar 06th 2012 ] - Market Wire

PAREXEL International to Present at Barclays Capital Healthcare Conference

[ Tue, Mar 06th 2012 ] - Market Wire

Threshold Pharmaceuticals Announces Oral Presenta .. 02 Clinical Study at the 2012 AACR Annual Meeting

Mon, March 5, 2012

[ Mon, Mar 05th 2012 ] - Market Wire

Onyx Pharmaceuticals International GmbH ernennt Luigi Costa zum Vice President of Europe

[ Mon, Mar 05th 2012 ] - Market Wire

World Renowned Harvard Medical School Professor a .. ox Anderson Speaks at The University of Hong Kong

[ Mon, Mar 05th 2012 ] - Market Wire

WellPoint Names New Executive Vice President, Senior Business, and Chief Transformation Officer

[ Mon, Mar 05th 2012 ] - Market Wire

InfuSystem Provides Update on Special Meeting of Stockholders

[ Mon, Mar 05th 2012 ] - Market Wire

Zions Bank "Speaking on Business" Features ZYTO Corp

[ Mon, Mar 05th 2012 ] - Market Wire

Jazz Pharmaceuticals Announces Public Offering of Ordinary Shares by Selling Shareholders

[ Mon, Mar 05th 2012 ] - Market Wire

Dr. Bogdan Dziurzynski Joins Anthera Pharmaceuticals Board of Directors

[ Mon, Mar 05th 2012 ] - Market Wire

Bernstein Liebhard LLP Announces That One Week Re .. med Investors to Make a Motion for Lead Plaintiff

Tribunal Federal de EE.UU. falla a favor de Allergan, Inc. y emite prohibicin permanente contra Merz Pharmaceuticals y Merz Aes

^{Published on 2012-03-12 08:57:25 - Market Wire}

IRVINE, California--([ BUSINESS WIRE ])--Allergan, Inc. (NYSE:AGN) confirma que el Juez de Distrito de EE.UU., Andrew J. Guilford, tras la realizacin de un juicio completo, ha establecido que Merz Pharmaceuticals y Merz Aesthetics han violado la Ley de Secretos Comerciales de California (Uniform Trade Secrets Act) y ha emitido una prohibicin permanente contra ellos. En una decisin por escrito, el Juez Guilford ha concluido que Merz se apropi indebidamente de importantes secretos comerciales pertenecientes a Allergan.

El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire